Medical Article

Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt…

A webinar on Thursday, December 12 from Noon to 1 pm ET will focus on how companies are meeting these challenges. The post How Can Employers Give Staff the Best Care Amidst Rising Healthcare Costs? appeared first on MedCity News.

While AI has the potential to streamline processes, its current use in the revenue cycle is resulting in more claim denials, payment delays, and a greater need for appeals, particularly because payers often use AI to retroactively review medical necessity determinations. The post How Payers are Using AI to Deny Claims and Dent Provider Revenue…

Dr. Eric Topol pointed out that while initial findings on generative AI in clinical settings are promising, they may not withstand the complexities of real-world clinical practice. The post Dr. Eric Topol: Generative AI Studies Boast Promising Results, But Real-World Challenges Remain appeared first on MedCity News.

Wearable devices, such as a glucose meter device or a defibrillator and pacemaker, can provide valuable and real-time information to a healthcare provider so that decisions can be made to protect the patient. The post Wearable Health Tech: Innovations and Impacts on Chronic Disease Management appeared first on MedCity News.

Sentara Health invested $11 million into smartphones for its nurses, equipping them with HIPAA-compliant devices to streamline communication, increase time at the bedside and improve patient outcomes. The program has been going on for a little more than a year — and Amy Rosa, the health system’s chief nursing informatics officer, says the initiative is…